Who is sponsoring NCT02911532?

NCT02911532 is sponsored by Shandong Eye Hospital.

What drugs are being tested in NCT02911532?

Interventions in NCT02911532: Tissue engineering conjunctiva transplantation.

Is NCT02911532 still recruiting?

NCT02911532 is currently status unknown. Last updated 16 August 2017.

Last reviewed 2017-08-16 · How we verify

NCT02911532: TECTPA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia

Status unknown NA Last updated 16 August 2017

What this trial tests

NA trial testing Tissue engineering conjunctiva transplantation in Pterygium in 60 participants. Status unknown.

Timeline

1 October 2016

Primary endpoint
1 October 2017

1 April 2018

Quick facts

Lead sponsor	Shandong Eye Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 October 2016
Primary completion	1 October 2017
Estimated completion	1 April 2018
Sites	1 location across China

Drugs / interventions tested

Tissue engineering conjunctiva transplantation

Conditions studied

Pterygium — all drugs for Pterygium →

Sponsor

Shandong Eye Hospital

Who can join

Adults 18 to 80, any sex, with Pterygium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether tissue engineering conjunctiva is effective in the treatment of pterygium and atretoblepharia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pterygium

Currently open trials in the same condition.

NCT06402643 — Comparison of Recurrence Between Mini-SLET and Limbal-Conjunctival Autograft Techniques in Primary Pterygium · NA · recruiting
NCT05456425 — A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium · Phase 3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02911532 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shandong Eye Hospital
Last refreshed: 16 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02911532.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing